CS208475B2 - Method of making the hydrogencitrate of the alcalic met - Google Patents

Method of making the hydrogencitrate of the alcalic met Download PDF

Info

Publication number
CS208475B2
CS208475B2 CS783982A CS398278A CS208475B2 CS 208475 B2 CS208475 B2 CS 208475B2 CS 783982 A CS783982 A CS 783982A CS 398278 A CS398278 A CS 398278A CS 208475 B2 CS208475 B2 CS 208475B2
Authority
CS
Czechoslovakia
Prior art keywords
citric acid
weight
citrate
urine
ions
Prior art date
Application number
CS783982A
Other languages
Czech (cs)
English (en)
Inventor
Rolf Madaus
Werner Stumpf
Klaus Goerler
Alfonso C Beltran
Original Assignee
Madaus & Co Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madaus & Co Dr filed Critical Madaus & Co Dr
Publication of CS208475B2 publication Critical patent/CS208475B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS783982A 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met CS208475B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2727304A DE2727304C2 (de) 1977-06-16 1977-06-16 Saures Alkalicitrat, dessen Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CS208475B2 true CS208475B2 (en) 1981-09-15

Family

ID=6011690

Family Applications (1)

Application Number Title Priority Date Filing Date
CS783982A CS208475B2 (en) 1977-06-16 1978-06-16 Method of making the hydrogencitrate of the alcalic met

Country Status (26)

Country Link
US (1) US4820870A (es)
JP (1) JPS545912A (es)
AR (1) AR219109A1 (es)
AU (1) AU519032B2 (es)
BE (1) BE868089A (es)
BG (1) BG41657A3 (es)
CA (1) CA1133506A (es)
CH (1) CH634813A5 (es)
CS (1) CS208475B2 (es)
DE (1) DE2727304C2 (es)
DK (1) DK270578A (es)
FR (1) FR2394513A1 (es)
GB (1) GB1583840A (es)
GR (1) GR64516B (es)
HK (1) HK46481A (es)
IL (1) IL54734A (es)
IT (1) IT1214864B (es)
MX (1) MX4999E (es)
NL (1) NL174345C (es)
PL (1) PL118528B1 (es)
PT (1) PT68096A (es)
RO (1) RO76941A (es)
SE (1) SE438851B (es)
SU (1) SU812167A3 (es)
YU (1) YU41105B (es)
ZA (1) ZA783409B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6393968A (ja) * 1986-10-06 1988-04-25 株式会社フジタ 地下立体駐車場
JPH02104870A (ja) * 1988-10-11 1990-04-17 Iwataro Moriyama 駐車装置
DE4328577C2 (de) * 1993-08-25 1997-09-11 Madaus Ag Alkalicitrate und deren Verwendung als Arzneimittel
EP0673913B1 (de) * 1994-03-23 1999-02-10 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
DE4409948A1 (de) * 1994-03-23 1995-09-28 Madaus Ag Calcium-Alkalicitratverbindungen und deren Verwendung als Arzneimittel
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
CA3041861A1 (en) * 2016-10-27 2018-05-03 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
PL238507B1 (pl) 2018-11-27 2021-08-30 Kozak Dariusz P H M Polcomm Wiertło z podwójnymi nacinakami
CN111116350A (zh) * 2019-12-28 2020-05-08 湖南九典制药股份有限公司 一种枸橼酸氢钾钠的制备方法
CN114404142B (zh) * 2022-02-23 2024-03-29 天津富勤科技股份有限公司 一种产生中性或弱酸性蒸汽的自发热眼罩

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE968843C (de) * 1953-11-29 1958-04-03 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von pharmakologisch wirksamen Magnesiumsalzen der Citronensaeure
DE1016251B (de) * 1955-01-22 1957-09-26 Adolf Christian Josef Opferman Verfahren zur Herstellung von zur Behandlung der Lungentuberkulose dienendem Monomagnesiumdicalciumcitrat
US3658969A (en) * 1969-11-14 1972-04-25 Codex Sa Pharmaceutical compositions useful in citric acid therapy

Also Published As

Publication number Publication date
DE2727304C2 (de) 1982-12-02
AU519032B2 (en) 1981-11-05
IL54734A0 (en) 1978-07-31
IL54734A (en) 1982-09-30
DK270578A (da) 1978-12-17
YU142778A (en) 1982-10-31
AU3716278A (en) 1979-12-20
CA1133506A (en) 1982-10-12
IT7824553A0 (it) 1978-06-14
GB1583840A (en) 1981-02-04
FR2394513A1 (fr) 1979-01-12
SU812167A3 (ru) 1981-03-07
CH634813A5 (de) 1983-02-28
GR64516B (en) 1980-04-09
BG41657A3 (en) 1987-07-15
AR219109A1 (es) 1980-07-31
DE2727304A1 (de) 1979-01-04
FR2394513B1 (es) 1982-11-19
JPS545912A (en) 1979-01-17
MX4999E (es) 1983-02-02
BE868089A (fr) 1978-12-14
RO76941A (ro) 1981-06-22
PL118528B1 (en) 1981-10-31
NL174345B (nl) 1984-01-02
ZA783409B (en) 1979-07-25
YU41105B (en) 1986-12-31
IT1214864B (it) 1990-01-18
SE438851B (sv) 1985-05-13
PT68096A (de) 1978-06-01
SE7806684L (sv) 1978-12-17
US4820870A (en) 1989-04-11
PL207657A1 (pl) 1979-06-04
NL7805747A (nl) 1978-12-19
NL174345C (nl) 1984-06-01
HK46481A (en) 1981-09-25

Similar Documents

Publication Publication Date Title
Prescott Pharmacokinetic drug interactions
US8759398B2 (en) Phosphorus binder composition for treatment of hyperphosphatemia
CS208475B2 (en) Method of making the hydrogencitrate of the alcalic met
SK12692001A3 (sk) Zmesi valdecoxibu
JP2003510243A (ja) 分子ヨウ素経口投与のための方法および医薬組成物
IE57793B1 (en) Orally administerable antidiabetic compositions
CZ20012661A3 (cs) Matricová tableta pro prodlouľené uvolňování gliclazidu po orálním podání
US5006551A (en) Composition for destroying malignant tumors
US20170312309A1 (en) Intradialytic administration of sodium thiosulfate
JP2021512081A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定な薬剤学的組成物
FR2688405A1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
IE60713B1 (en) Use of athiazide diuretic for the manufacture of a non-diuretic antihypertensive medicament
CA3009332A1 (en) Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereof
EP0074426B1 (en) Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
JP2811331B2 (ja) 骨形成促進剤
JP2009526086A (ja) 燐酸過剰血による病気を治療する薬物及びその製造方法
JP6063939B2 (ja) Ｌ−ヒスチジンおよびその誘導体の新規用途
US7855191B2 (en) Agent having a destructive effect on malignant tumors and method for the production thereof
WO2022216294A1 (en) Powder for oral suspension containing tadalafil
JP2022541948A (ja) エソメプラゾール及び炭酸水素ナトリウムを含む安定した薬学的組成物
KR20130047262A (ko) 제어된 방출성의 아스코르빈산 함유 경구용 정제 조성물 및 그 분석방법
RU2101014C1 (ru) Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
KR101324425B1 (ko) 증가된 비스포스포네이트의 생체이용률을 가지는 경구투여 약제
Sjoden et al. Calcium absorption and excretion in patients treated with verapamil.
JPH11255642A (ja) 骨組織傷害の予防又は処置のため及び骨構造要素の強化のための医薬品ならびに該医薬品の製法